CyDex Pharmaceuticals' Series B Round

CyDex Pharmaceuticals raised a round of funding on August 20, 2004.

CyDex Pharmaceuticals develops drugs specifically designed to address limitations of current therapies for conditions such as bipolar disorder, schizophrenia, fungus, and canine motion sickness.…

Articles about CyDex Pharmaceuticals' Series B Round: